| List Name |
Annotation |
Enrichment |
p-value |
| protein amino acid dephosphorylation |
AmiGO Browser |
4.98 |
3.60e-03 |
| immune effector process |
AmiGO Browser |
5.66 |
5.79e-03 |
| dephosphorylation |
AmiGO Browser |
4.44 |
5.85e-03 |
| phosphate metabolic process |
AmiGO Browser |
2.02 |
0.01 |
| phosphorus metabolic process |
AmiGO Browser |
2.02 |
0.01 |
| transmembrane receptor protein serine/threonine kinase signaling pathway |
AmiGO Browser |
5.83 |
0.02 |
| apoptosis |
AmiGO Browser |
2.06 |
0.02 |
| programmed cell death |
AmiGO Browser |
2.05 |
0.02 |
| leukocyte mediated immunity |
AmiGO Browser |
4.89 |
0.02 |
| ectodermal gut development |
AmiGO Browser |
33.71 |
0.03 |
| ectodermal gut morphogenesis |
AmiGO Browser |
33.71 |
0.03 |
| death |
AmiGO Browser |
1.93 |
0.03 |
| cell death |
AmiGO Browser |
1.93 |
0.03 |
| lymphocyte costimulation |
AmiGO Browser |
28.90 |
0.03 |
| T cell costimulation |
AmiGO Browser |
28.90 |
0.03 |
| gut morphogenesis |
AmiGO Browser |
25.28 |
0.04 |
| ribonucleotide catabolic process |
AmiGO Browser |
22.47 |
0.04 |
| liver development |
AmiGO Browser |
22.47 |
0.04 |
| transforming growth factor beta receptor signaling pathway |
AmiGO Browser |
6.04 |
0.04 |
| vesicle-mediated transport |
AmiGO Browser |
2.16 |
0.05 |
| endocytosis |
AmiGO Browser |
2.97 |
0.05 |
| membrane invagination |
AmiGO Browser |
2.97 |
0.05 |
| immunoglobulin secretion |
AmiGO Browser |
20.23 |
0.05 |
| negative regulation of defense response |
AmiGO Browser |
18.39 |
0.05 |
| embryonic digit morphogenesis |
AmiGO Browser |
18.39 |
0.05 |
| caspase activation via cytochrome c |
AmiGO Browser |
18.39 |
0.05 |
| digestive tract morphogenesis |
AmiGO Browser |
18.39 |
0.05 |
| leukocyte degranulation |
AmiGO Browser |
18.39 |
0.05 |
| negative regulation of inflammatory response |
AmiGO Browser |
18.39 |
0.05 |
| positive regulation of JNK cascade |
AmiGO Browser |
16.86 |
0.06 |
| skeletal morphogenesis |
AmiGO Browser |
15.56 |
0.06 |
| regulation of interleukin-12 biosynthetic process |
AmiGO Browser |
15.56 |
0.06 |
| embryonic organ morphogenesis |
AmiGO Browser |
15.56 |
0.06 |
| T cell differentiation in the thymus |
AmiGO Browser |
15.56 |
0.06 |
| oogenesis |
AmiGO Browser |
15.56 |
0.06 |
| thymic T cell selection |
AmiGO Browser |
15.56 |
0.06 |
| interleukin-12 biosynthetic process |
AmiGO Browser |
15.56 |
0.06 |
| thymus development |
AmiGO Browser |
15.56 |
0.06 |
| negative regulation of growth |
AmiGO Browser |
4.87 |
0.06 |
| regulation of cytokine biosynthetic process |
AmiGO Browser |
4.76 |
0.07 |
| gut development |
AmiGO Browser |
14.45 |
0.07 |
| mast cell activation |
AmiGO Browser |
14.45 |
0.07 |
| regulation of T cell mediated immunity |
AmiGO Browser |
13.48 |
0.07 |
| post-translational protein modification |
AmiGO Browser |
1.54 |
0.08 |
| skeletal development |
AmiGO Browser |
2.47 |
0.08 |
| humoral immune response |
AmiGO Browser |
4.26 |
0.08 |
| regulation of lymphocyte mediated immunity |
AmiGO Browser |
11.90 |
0.08 |
| memory |
AmiGO Browser |
11.90 |
0.08 |
| regulation of leukocyte mediated immunity |
AmiGO Browser |
11.90 |
0.08 |
| acute inflammatory response |
AmiGO Browser |
4.21 |
0.08 |
| T cell selection |
AmiGO Browser |
11.24 |
0.09 |
| S phase of mitotic cell cycle |
AmiGO Browser |
11.24 |
0.09 |
| interleukin-12 production |
AmiGO Browser |
11.24 |
0.09 |
| S phase |
AmiGO Browser |
11.24 |
0.09 |
| cytokine biosynthetic process |
AmiGO Browser |
4.09 |
0.09 |
| cytokine metabolic process |
AmiGO Browser |
4.05 |
0.09 |
| gastrulation (sensu Vertebrata) |
AmiGO Browser |
10.65 |
0.09 |
| negative regulation of T cell proliferation |
AmiGO Browser |
10.65 |
0.09 |
| water-soluble vitamin biosynthetic process |
AmiGO Browser |
10.65 |
0.09 |
| gastrulation with mouth forming second |
AmiGO Browser |
10.65 |
0.09 |
| induction of apoptosis |
AmiGO Browser |
2.37 |
0.09 |
| positive regulation of hydrolase activity |
AmiGO Browser |
3.97 |
0.09 |
| induction of programmed cell death |
AmiGO Browser |
2.36 |
0.09 |
| negative regulation of immune response |
AmiGO Browser |
10.11 |
0.09 |
| purine nucleoside monophosphate metabolic process |
AmiGO Browser |
10.11 |
0.09 |
| purine nucleoside monophosphate biosynthetic process |
AmiGO Browser |
10.11 |
0.09 |
| negative regulation of immune system process |
AmiGO Browser |
10.11 |
0.09 |
| purine ribonucleoside monophosphate metabolic process |
AmiGO Browser |
10.11 |
0.09 |
| regulation of immune effector process |
AmiGO Browser |
10.11 |
0.09 |
| purine ribonucleoside monophosphate biosynthetic process |
AmiGO Browser |
10.11 |
0.09 |
| negative regulation of progression through cell cycle |
AmiGO Browser |
2.33 |
0.10 |
| regulation of apoptosis |
AmiGO Browser |
1.80 |
0.10 |
| vitamin biosynthetic process |
AmiGO Browser |
9.63 |
0.10 |
| negative regulation of cell proliferation |
AmiGO Browser |
2.29 |
0.10 |
| purine ribonucleotide metabolic process |
AmiGO Browser |
3.75 |
0.10 |
| regulation of programmed cell death |
AmiGO Browser |
1.79 |
0.10 |
| negative regulation of T cell activation |
AmiGO Browser |
9.19 |
0.10 |
| nucleotide catabolic process |
AmiGO Browser |
9.19 |
0.10 |
L2L Microarray Analysis Tool